Skin ConditionNCT04709588
Hydrolyzed Collagen Combined With Djulis and Green Caviar Improve Skin Condition
A study testing collagen drinkss in people with Skin Condition, run by TCI Co., Ltd. at 1 site in Taiwan.
Trial summary
Collagen combined with djulis and green caviar improve skin condition Read more about this study
- Who is it for?
- Ages 20 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Skin Condition
- What is being tested?
- collagen drinkss
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 50 participants
- Where
- 1 siteTaiwan
- Study dates
- 1 May 2020to 31 Aug 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Dry skin
- Rough skin
- Large pores
- Dark yellow complexion
- Sagging skin
Who cannot join
- Skin disorders
- Liver diseases
- Kidney diseases
- Allergy to cosmetics, drugs, or foods
- Pregnant and lactating women
- People who had any cosmetic procedures before 4 weeks of the study
Show all 9Show fewer
- Area of facial spot over 3 cm2
- Vegan
- People who took collagen supplements in the past 3 months.
Trial locations and contacts
1 site in 1 country.
About this study
Collagen combined with djulis and green caviar improve skin condition
Read the detailed description
Using collagen drinks combined fish collagen with djulis, and green caviar to improve skin condition.
- Conditions
- Skin Condition
- Being tested
- placebo group, collagen drinkss
- Medical subject headings
- Skin Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
placebo groupDietary supplement
subjects drank 50 ml every night for 14, 28 days
collagen drinkssDietary supplement
subjects drank 50 ml every night for 14, 28 days
| Study group | Role | What they receive |
|---|---|---|
| placebo group | Placebo comparator | subjects drank 50 ml every night for 14, 28 days Receives: Dietary Supplement: placebo group |
| collagen drinks | Experimental | subjects drank 50 ml every night for 14, 28 days Receives: Dietary Supplement: collagen drinkss |
What is being measured
The primary outcome is the main question the study is designed to answer.
skin moisture
using corneometer CM825 to examine skin moisture (The higher the value, the more water content, C.U., corneometer units )
Measured: subjects drank 50 ml every night for 28 days
skin elasticity
using cutometer dual MPA580 to examine skin elasticity (The closer the R2 value is to 1, the better the elasticity and no unit)
Measured: subjects drank 50 ml every night for 28 days
skin gloss
using probe system GL2000 \& MPA10 to examine skin gloss (The higher the value, the higher the gloss, no unit)
Measured: subjects drank 50 ml every night for 28 days
skin spot
usig VISIA-CR to examine skin spot (The higher the value, the larger the pore area, mm2)
Measured: subjects drank 50 ml every night for 28 days
skin wrinkle
using VISIOSCAN-VC20 to examine skin wrinkle (The higher the value, the more wrinkles, surface evaluation of wrinkles, SEW)
Measured: subjects drank 50 ml every night for 28 days
skin roughness
using VISIOSCAN-VC98 to examine skin roughness (The higher the value, the higher the roughness, surface evaluation of roughness, SEr)
Measured: subjects drank 50 ml every night for 28 days
skin smoothness
using VISIOSCAN-VC98 to examine skin smoothness (The lower the value, the higher the smoothness, surface evaluation of smoothness, SEsm)
Measured: subjects drank 50 ml every night for 28 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jan 2021
- Study start1 May 2020
- Primary completion30 Jun 2020
- Study completion31 Aug 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Skin ConditionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- TCI Co., Ltd.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Chi Fu Chiang, Ph.D, Principal investigator, Research & Design Center, TCI CO., Ltd
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04709588
- Sponsor's protocol ID
- EWISH-20190917-01
- Status last verified
- Jan 2021
- First submitted
- 11 Jan 2021
- Last updated
- 14 Jan 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Jan 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Hydrolyzed Collagen Combined With Djulis and Green Caviar Improve Skin Condition
- ClinicalTrials.gov ID
- NCT04709588
- Acronym / sponsor ID
- EWISH-20190917-01
- Conditions
- Skin Condition
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- TCI Co., Ltd.Industry (pharma, biotech, devices)
- Study start
- 1 May 2020 (actual)
- Primary completion
- 30 Jun 2020 (actual)
- Study completion
- 31 Aug 2020 (actual)
- First posted
- 14 Jan 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Collagen combined with djulis and green caviar improve skin condition
Detailed description
Using collagen drinks combined fish collagen with djulis, and green caviar to improve skin condition.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| placebo group | Placebo comparator | Dietary Supplement: placebo groupsubjects drank 50 ml every night for 14, 28 days |
| collagen drinks | Experimental | Dietary Supplement: collagen drinksssubjects drank 50 ml every night for 14, 28 days |
Who may qualify
- Ages
- 20 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Dry skin
- Rough skin
- Large pores
- Dark yellow complexion
- Sagging skin
Key exclusion criteria (9 listed)
- Skin disorders
- Liver diseases
- Kidney diseases
- Allergy to cosmetics, drugs, or foods
- Pregnant and lactating women
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| placebo groupsubjects drank 50 ml every night for 14, 28 days | Dietary supplement | placebo group |
| collagen drinksssubjects drank 50 ml every night for 14, 28 days | Dietary supplement | collagen drinks |
Primary outcome
skin moisture
Time frame: subjects drank 50 ml every night for 28 days
using corneometer CM825 to examine skin moisture (The higher the value, the more water content, C.U., corneometer units )
skin elasticity
Time frame: subjects drank 50 ml every night for 28 days
using cutometer dual MPA580 to examine skin elasticity (The closer the R2 value is to 1, the better the elasticity and no unit)
skin gloss
Time frame: subjects drank 50 ml every night for 28 days
using probe system GL2000 \& MPA10 to examine skin gloss (The higher the value, the higher the gloss, no unit)
skin spot
Time frame: subjects drank 50 ml every night for 28 days
usig VISIA-CR to examine skin spot (The higher the value, the larger the pore area, mm2)
skin wrinkle
Time frame: subjects drank 50 ml every night for 28 days
using VISIOSCAN-VC20 to examine skin wrinkle (The higher the value, the more wrinkles, surface evaluation of wrinkles, SEW)
skin roughness
Time frame: subjects drank 50 ml every night for 28 days
using VISIOSCAN-VC98 to examine skin roughness (The higher the value, the higher the roughness, surface evaluation of roughness, SEr)
skin smoothness
Time frame: subjects drank 50 ml every night for 28 days
using VISIOSCAN-VC98 to examine skin smoothness (The lower the value, the higher the smoothness, surface evaluation of smoothness, SEsm)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jan 2021.
- Individual participant dataSharing planned: No
Related trials for Skin Condition
Not yet recruitingPhase 2
Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)
Moderate to Severe Psoriatic Arthritis
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingPhase 1
IL-17 Blockade to Decrease irAEs (REPLAY)
Metastatic Melanoma
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Chi Fu Chiang, Ph.D principal investigator
Research & Design Center, TCI CO., Ltd
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing collagen drinkss in people with Skin Condition, run by TCI Co., Ltd. at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
skin moisture (time frame: subjects drank 50 ml every night for 28 days). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2021.